---
figid: PMC4157394__nihms615874f12
figlink: /pmc/articles/PMC4157394/figure/F12/
number: Fig. 12
caption: Inhibition of protein synthesis by rocaglamides. The Ras-Raf-MEK-ERK and
  the PI3K-AKT-mTOR pathways play a central role in regulation of cap-dependent translation
  by activation of the eukaryotic translation initiation factor 4E (eIF4E). eIF4E
  binds to the 5′ cap structure and assembles eIF4G and eIF4A to initiate translation.
  Rocaglamide congeners 23 and 35 directly bind to and inhibit eIF4A function. Rocaglamides
  1, 4, 7 and 50 block the MEK-REK pathway and inhibit eIF4E cap binding activity
pmcid: PMC4157394
papertitle: Chemistry and Biology of Rocaglamides (= Flavaglines) and Related Derivatives
  from Aglaia Species (Meliaceae).
reftext: Sherif S. Ebada, et al. Prog Chem Org Nat Prod. ;94:1-58.
pmc_ranked_result_index: '109754'
pathway_score: 0.918939
filename: nihms615874f12.jpg
figtitle: Inhibition of protein synthesis by rocaglamides
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4157394__nihms615874f12.html
  '@type': Dataset
  description: Inhibition of protein synthesis by rocaglamides. The Ras-Raf-MEK-ERK
    and the PI3K-AKT-mTOR pathways play a central role in regulation of cap-dependent
    translation by activation of the eukaryotic translation initiation factor 4E (eIF4E).
    eIF4E binds to the 5′ cap structure and assembles eIF4G and eIF4A to initiate
    translation. Rocaglamide congeners 23 and 35 directly bind to and inhibit eIF4A
    function. Rocaglamides 1, 4, 7 and 50 block the MEK-REK pathway and inhibit eIF4E
    cap binding activity
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - AKT1
  - SOS1
  - ARAF
  - RAF1
  - RHEB
  - TSC2
  - AKT2
  - BRAF
  - MAPK1
  - MTOR
  - PTEN
  - MKNK1
  - SOS2
  - TSC1
  - GRB2
  - AKT3
  - Rocaglamide
  - rocaglamide
  - Silvestrol
  - Rapamycin
  - Cancer
genes:
- word: (ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Akt/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: (ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN)
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Mnk1
  symbol: MNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MKNK1
  entrez: '8569'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals:
- word: Rocaglamide
  source: MESH
  identifier: C107772
- word: rocaglamide
  source: MESH
  identifier: C107772
- word: Silvestrol
  source: MESH
  identifier: C489897
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
